Cargando…
Bone Scan Index: a prognostic imaging biomarker for high-risk prostate cancer patients receiving primary hormonal therapy
BACKGROUND: The objective of this study was to explore the prognostic value of the Bone Scan Index (BSI) obtained at the time of diagnosis in a group of high-risk prostate cancer patients receiving primary hormonal therapy. METHODS: This was a retrospective study based on 130 consecutive prostate ca...
Autores principales: | Kaboteh, Reza, Damber, Jan-Erik, Gjertsson, Peter, Höglund, Peter, Lomsky, Milan, Ohlsson, Mattias, Edenbrandt, Lars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570487/ https://www.ncbi.nlm.nih.gov/pubmed/23384286 http://dx.doi.org/10.1186/2191-219X-3-9 |
Ejemplares similares
-
Progression of bone metastases in patients with prostate cancer - automated detection of new lesions and calculation of bone scan index
por: Kaboteh, Reza, et al.
Publicado: (2013) -
Bone Scan Index as a prognostic imaging biomarker during androgen deprivation
therapy
por: Reza, Mariana, et al.
Publicado: (2014) -
Normal limits for left ventricular ejection fraction and volumes determined by gated single photon emission computed tomography – a comparison between two quantification methods
por: Lomsky, Milan, et al.
Publicado: (2008) -
Analysis of regional bone scan index measurements for the survival of patients with prostate cancer
por: Kalderstam, Jonas, et al.
Publicado: (2014) -
Diagnostic evaluation of three cardiac software packages using a consecutive group of patients
por: Johansson, Lena, et al.
Publicado: (2011)